Labocort may be available in the countries listed below.
Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Labocort in the following countries:
International Drug Name Search
Losamet may be available in the countries listed below.
Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losamet in the following countries:
International Drug Name Search
Clorazepaatdikalium PCH may be available in the countries listed below.
Dipotassium Clorazepate is reported as an ingredient of Clorazepaatdikalium PCH in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Phenylbutazone is reported as an ingredient of Butequine in the following countries:
International Drug Name Search
Naphtears may be available in the countries listed below.
Naphazoline is reported as an ingredient of Naphtears in the following countries:
Naphazoline hydrochloride (a derivative of Naphazoline) is reported as an ingredient of Naphtears in the following countries:
International Drug Name Search
In the US, Zinc Acetate (zinc acetate systemic) is a member of the drug class minerals and electrolytes and is used to treat Wilson's Disease and Zinc Deficiency.
US matches:
Ph. Eur.
A16AX05
0005970-45-6
C4-H6-O4-Zn·2H2O
219
Antiseptic
Astringent agent
Acetic acid, zinc salt, dihydrate (USP)
Zinc acetate, dihydrate (USP)
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| PH | Pharmacopoeia Name |
| Ph. Eur. | European Pharmacopoeia |
| USP | Pharmacopoeia of the United States |
Lormetazepam PCH may be available in the countries listed below.
Lormetazepam is reported as an ingredient of Lormetazepam PCH in the following countries:
International Drug Name Search
Losan D may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Losan D in the following countries:
Losartan is reported as an ingredient of Losan D in the following countries:
International Drug Name Search
Liduc M may be available in the countries listed below.
Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Liduc M in the following countries:
International Drug Name Search
Linipon may be available in the countries listed below.
Risperidone is reported as an ingredient of Linipon in the following countries:
International Drug Name Search
Liberprost may be available in the countries listed below.
Bicalutamide is reported as an ingredient of Liberprost in the following countries:
International Drug Name Search
Treating moderate to severe pain in certain patients.
Oxymorphone is an opioid (narcotic) analgesic. It works by binding to certain receptors in the brain and nervous system to reduce pain.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Oxymorphone. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Oxymorphone. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Oxymorphone may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Oxymorphone as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Oxymorphone.
When used for long periods of time or at high doses, Oxymorphone may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Oxymorphone stops working well. Do not take more than prescribed.
Some people who use Oxymorphone for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. Dependence is unlikely to be an issue in terminally ill patients where comfort is more important. If you are taking Oxymorphone regularly, do not suddenly stop taking it without checking with your doctor. WITHDRAWAL symptoms have occurred when Oxymorphone is suddenly stopped and may include anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea and vomiting; pain; rigid muscles; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping. Contact your doctor if you notice any of these symptoms after stopping Oxymorphone.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Anxiety; constipation; dizziness; drowsiness; dry mouth; gas; headache; lightheadedness; nausea; sweating; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; fainting; fast, slow, or irregular heartbeat; fever; hallucinations; mental or mood changes; seizure; severe or persistent dizziness or drowsiness; severe or persistent headache or vomiting; shallow, slowed, or difficult breathing; trouble urinating; unusual swelling; vision changes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Oxymorphone side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bluish skin; chest pain; cold and clammy skin; coma; difficult or slow breathing; limp muscles; numbness of an arm or leg; pinpoint pupils; severe drowsiness or dizziness; slow or irregular heartbeat.
Store Oxymorphone at 77 degrees F (25 degrees C). Store away from heat, moisture, and light. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Do not store Oxymorphone in the bathroom. Keep Oxymorphone out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Oxymorphone. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Lenistar may be available in the countries listed below.
Butamirate citrate (a derivative of Butamirate) is reported as an ingredient of Lenistar in the following countries:
International Drug Name Search
In the US, Labetalol (labetalol systemic) is a member of the drug class non-cardioselective beta blockers and is used to treat High Blood Pressure, Hypertensive Emergency, Mitral Valve Prolapse and Pheochromocytoma.
US matches:
Rec.INN
C07AG01
0036894-69-6
C19-H24-N2-O3
328
ß-Adrenergic blocking agent
α-Adrenergic blocking agent
Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Lacryvisc SE may be available in the countries listed below.
Carbomer is reported as an ingredient of Lacryvisc SE in the following countries:
International Drug Name Search
Losaprol may be available in the countries listed below.
Omeprazole is reported as an ingredient of Losaprol in the following countries:
International Drug Name Search
Bascul may be available in the countries listed below.
Sulfamethoxazole is reported as an ingredient of Bascul in the following countries:
Trimethoprim is reported as an ingredient of Bascul in the following countries:
International Drug Name Search
Lormine may be available in the countries listed below.
Dexamethasone is reported as an ingredient of Lormine in the following countries:
International Drug Name Search
Salicylic Acid is reported as an ingredient of Clear Away in the following countries:
International Drug Name Search
Tildiem may be available in the countries listed below.
UK matches:
Diltiazem is reported as an ingredient of Tildiem in the following countries:
Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Tildiem in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Lotagen may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Policresulen is reported as an ingredient of Lotagen in the following countries:
International Drug Name Search
Themigrel may be available in the countries listed below.
Clopidogrel hydrogen sulfate (a derivative of Clopidogrel) is reported as an ingredient of Themigrel in the following countries:
International Drug Name Search
Lorzaar Orifarm may be available in the countries listed below.
Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Lorzaar Orifarm in the following countries:
International Drug Name Search
Lactapen G may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Lactapen G in the following countries:
International Drug Name Search
Loron may be available in the countries listed below.
UK matches:
Clodronic Acid disodium tetrahydrate (a derivative of Clodronic Acid) is reported as an ingredient of Loron in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Leuprorelin Sandoz may be available in the countries listed below.
Leuprorelin acetate (a derivative of Leuprorelin) is reported as an ingredient of Leuprorelin Sandoz in the following countries:
International Drug Name Search
Lipirate may be available in the countries listed below.
Fenofibrate is reported as an ingredient of Lipirate in the following countries:
International Drug Name Search
Laclorhex may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Laclorhex in the following countries:
International Drug Name Search
Fluorcalcic may be available in the countries listed below.
Sodium Fluoride is reported as an ingredient of Fluorcalcic in the following countries:
International Drug Name Search
Lacril may be available in the countries listed below.
Methylcellulose is reported as an ingredient of Lacril in the following countries:
International Drug Name Search
Lacovin may be available in the countries listed below.
Minoxidil is reported as an ingredient of Lacovin in the following countries:
International Drug Name Search
Loricid may be available in the countries listed below.
Allopurinol is reported as an ingredient of Loricid in the following countries:
International Drug Name Search
Lormetazepam Alter may be available in the countries listed below.
Lormetazepam is reported as an ingredient of Lormetazepam Alter in the following countries:
International Drug Name Search
Relieving pain and inflammation in the ear caused by certain ear conditions. It may be used with antibiotics given by mouth to treat certain ear infections. It may also be used to help remove a buildup of earwax.
Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol is an antibacterial, analgesic, and anesthetic combination. It works by relieving pressure and reducing inflammation, congestion, pain, and discomfort.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol. However, no specific interactions with Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol are known at this time.
Ask your health care provider if Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol.
All medicines may cause side effects, but many people have no, or minor, side effects. When used in small doses, no COMMON side effects have been reported with Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol. Seek medical attention right away if any of these SEVERE side effects occur:
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); irritation not present when you began using Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch .
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Protect from freezing. Keep the container tightly closed. Store away from heat, moisture, and light. Keep Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Acetic Acid/Antipyrine/Benzocaine/U-Polycosanol. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Hexatron may be available in the countries listed below.
Tranexamic Acid is reported as an ingredient of Hexatron in the following countries:
International Drug Name Search
Generic Name: sodium nitrite and sodium thiosulfate (Intravenous route)
SOE-dee-um NYE-trite, SOE-dee-um thye-oh-SUL-fate
Sodium nitrite can cause serious adverse reactions and death from hypotension and methemoglobin formation, even at doses less than twice the recommended therapeutic dose. Hypotension and methemoglobin formation can occur concurrently or separately. Patients should be closely monitored to ensure adequate perfusion and oxygenation during treatment with sodium nitrite. Alternative therapeutic approaches should be considered in patients known to have diminished oxygen or cardiovascular reserve and in those at higher risk of developing methemoglobinemia .
In the U.S.
Available Dosage Forms:
Sodium nitrite and sodium thiosulfate injection are used together to treat cyanide poisoning. Cyanide poisoning is a life-threatening condition that requires immediate medical attention.
This medicine is to be given only by or under the direct supervision of a doctor.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of sodium nitrite and sodium thiosulfate injection in the pediatric population. However, because cyanide poisoning is a life-threatening condition, it is used in the pediatric population. Recommended doses should not be exceeded, and the patient should be carefully monitored during treatment.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of sodium nitrite and sodium thiosulfate injection in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving sodium nitrite and sodium thiosulfate injection.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
A nurse or other trained health professional will give you or your child this medicine in a hospital. This medicine is given through a needle placed in one of your veins.
Your doctor will check your or your child's progress closely while you are receiving this medicine. This will allow your doctor to see if the medicine is working properly. Blood tests will also be needed to check for unwanted effects.
Severe hypotension (low blood pressure) may occur with this medicine. It could be life-threatening and requires immediate medical attention. Your doctor will measure your blood pressure and keep it from going too low while you are receiving this medicine.
This medicine may cause a rare, but serious blood problem called methemoglobinemia. Newborn babies and infants may be more likely to have this serious side effect. Your doctor will measure how much methemoglobin is in your blood and keep it from going too high while you are receiving this medicine.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Losartan Atid may be available in the countries listed below.
Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Atid in the following countries:
International Drug Name Search
Neo-Mercazole may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Carbimazole is reported as an ingredient of Neo-Mercazole in the following countries:
International Drug Name Search
Fedrin may be available in the countries listed below.
Ephedrine hydrochloride (a derivative of Ephedrine) is reported as an ingredient of Fedrin in the following countries:
International Drug Name Search
Lacrybiotic may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Chloramphenicol is reported as an ingredient of Lacrybiotic in the following countries:
International Drug Name Search
The following drugs and medications are in some way related to, or used in the treatment of Infection Prophylaxis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Loperamide HCl Hexal may be available in the countries listed below.
Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Loperamide HCl Hexal in the following countries:
International Drug Name Search
Lacdigest may be available in the countries listed below.
Tilactase is reported as an ingredient of Lacdigest in the following countries:
International Drug Name Search
Laroxyl may be available in the countries listed below.
Amitriptyline is reported as an ingredient of Laroxyl in the following countries:
Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Laroxyl in the following countries:
International Drug Name Search
Lipotropic may be available in the countries listed below.
Atorvastatin is reported as an ingredient of Lipotropic in the following countries:
International Drug Name Search
Dilatrate-SR is a brand name of isosorbide dinitrate, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Dilatrate-SR available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dilatrate-SR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Dilatrate-SR.
There are currently no drugs listed for "Leukocytosis". See Blood Disorders.
Definition of Leukocytosis: An abnormally large increase in the number of white blood cells in the blood, often occurring during an acute infection or inflammation.
Generic Name: estrogen (Vaginal route)
In the U.S.
In Canada
Available Dosage Forms:
Estrogens are hormones produced by the body. Among other things, estrogens help develop and maintain female organs.
When your body is in short supply of this hormone, replacing it can ease the uncomfortable changes that occur in the vagina, vulva (female genitals), and urethra (part of the urinary system). Conditions that are treated with vaginal estrogens include a genital skin condition (vulvar atrophy), inflammation of the vagina (atrophic vaginitis), and inflammation of the urethra (atrophic urethritis).
Estrogens work partly by increasing a normal clear discharge from the vagina and making the vulva and urethra healthy. Using or applying an estrogen relieves or lessens:
When used vaginally or on the skin, most estrogens are absorbed into the bloodstream and cause some, but not all, of the same effects as when they are taken by mouth. Estrogens used vaginally at very low doses for treating local problems of the genitals and urinary system will not protect against osteoporosis or stop the hot flushes caused by menopause.
Estrogens for vaginal use are available only with your doctor's prescription.
Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Estrogen vaginal cream is not indicated in children. Studies have not been conducted.
Elderly women greater than 65 years of age may have an increased risk of certain side effects during treatment, especially stroke, invasive breast cancer, and memory problems.
Estrogens should not be used during pregnancy, since an estrogen called diethylstilbestrol (DES) that is no longer taken for hormone replacement has caused serious birth defects in humans and animals.
Use of this medicine is not recommended in nursing mothers. Estrogens pass into the breast milk and may decrease the amount and quality of breast milk. Caution should be exercised in mothers who are using estrogen and breast-feeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of medicines in this class. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain estrogen. It may not be specific to Estring. Please read with care.
Vaginal estrogen products usually come with patient directions. Read them carefully before using this medicine.
Wash your hands before and after using the medicine. Also, keep the medicine out of your eyes. If this medicine does get into your eyes, wash them out immediately, but carefully, with large amounts of tap water. If your eyes still burn or are painful, check with your doctor.
Use this medicine only as directed. Do not use more of it and do not use it for a longer time than your doctor ordered. It can take up to 4 months to see the full effect of the estrogens. Your doctor may reconsider continuing your estrogen treatment or may lower your dose several times within the first one or two months, and every 3 to 6 months after that. Sometimes a switch to oral estrogens may be required for added benefits or for higher doses. When using the estradiol vaginal insert or ring, you will need to replace it every 3 months or remove it after 3 months.
For vaginal creams or suppositories:
For vaginal insert or ring dosage form:
The dose medicines in this class will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of these medicines. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
When using the suppository or cream several times a week: If you miss a dose of this medicine and remember it within 1 or 2 days of the missed dose, use the missed dose as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
When using the cream or suppositories more than several times a week: If you miss a dose of this medicine, use it as soon as possible if remembered within 12 hours of the missed dose. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Keep out of the reach of children.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Do not keep outdated medicine or medicine no longer needed.
It is very important that your doctor check your progress at regular visits to make sure this medicine does not cause unwanted effects. Plan on going to see your doctor every year, but some doctors require visits more often.
It is not yet known whether the use of vaginal estrogens increases the risk of breast cancer in women. It is very important that you check your breasts on a regular basis for any unusual lumps or discharge. Report any problems to your doctor. You should also have a mammogram (x-ray picture of the breasts) done if your doctor recommends it.
It is important that you have a regular pelvic exam (pap smear). Your doctor will tell you how often this exam should be done.
Talk to your doctor if you have high blood pressure, high cholesterol (fats in the blood), or diabetes, use tobacco, or are overweight. You may have a higher risk for getting heart disease.
Although the chance is low, use of estrogen may increase your chance of getting cancer of the ovary or uterus (womb). Regular visits to your health professional can help identify these serious side effects early.
If you think that you may be pregnant, stop using the medicine immediately and check with your doctor.
Tell the doctor in charge that you are using this medicine before having any laboratory test, because some test results may be affected.
For vaginal creams or suppositories:
For estradiol vaginal inserts or rings:
The risk of any serious adverse effect is unlikely for most women using low doses of estrogens vaginally. Even women with special risks have used vaginal estrogens without problems.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Also, many women who are using estrogens with a progestin (another female hormone) will start having monthly vaginal bleeding that is similar to menstrual periods. This effect will continue for as long as the medicine is taken. However, monthly bleeding will not occur in women who have had the uterus removed by surgery (hysterectomy).
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Cervoxan may be available in the countries listed below.
Vinburnine is reported as an ingredient of Cervoxan in the following countries:
International Drug Name Search
Albucid may be available in the countries listed below.
Sulfacetamide sodium salt (a derivative of Sulfacetamide) is reported as an ingredient of Albucid in the following countries:
International Drug Name Search
Boots Cream of Magnesia B.P.
(Magnesium Oxide, Magnesium Sulphate)
Relieves constipation
Relieves acid indigestion
e 200 ml
Read all of this label for full instructions.
This effective formulation contains an antacid to neutralise excess acid and relieve indigestion. It also contains a laxative to relieve constipation.
Check the cap seal is not broken before first use. If it is, do not take the medicine. Shake the bottle well.
Do not give to children under 6 years, unless your doctor tells you to.
Do not take regularly, or for long periods of time, (more than a week) unless your doctor tells you to.
If symptoms do not go away talk to your doctor.
You may get watery diarrhoea or stomach pain. Talk to a doctor straight away if this happens.
Most people will not have problems, but some may get some of these:
Do not freeze.
Keep all medicines out of the sight and reach of children.
Use by the date on the label edge.
Each 5 ml of emulsion contains Magnesium Oxide 5.98% w/v, Magnesium Sulphate 0.075% w/v.
Also contains: purified water, chloroform.
PL 00014/5304
Text prepared 11/07
If you need more advice ask your pharmacist.
BTC 17709 vF 25/01/08
